Analysts Set Cabot Corporation (NYSE:CBT) Target Price at $85.80

Shares of Cabot Corporation (NYSE:CBT) have received a consensus recommendation of “Hold” from the seven brokerages that are presently covering the stock, Marketbeat.com reports. One analyst has rated the stock with a sell rating, four have issued a hold rating and two have assigned a buy rating to the company. The average twelve-month target price among analysts that have issued a report on the stock in the last year is $85.80.

Several analysts have weighed in on CBT shares. Wall Street Zen raised Cabot from a “hold” rating to a “buy” rating in a report on Sunday, June 14th. Mizuho raised their target price on shares of Cabot from $80.00 to $90.00 and gave the company a “neutral” rating in a research note on Thursday, June 25th. UBS Group lifted their price target on shares of Cabot from $81.00 to $86.00 and gave the stock a “neutral” rating in a research report on Friday, May 8th. JPMorgan Chase & Co. boosted their price target on shares of Cabot from $68.00 to $70.00 and gave the stock an “underweight” rating in a research note on Wednesday, May 13th. Finally, Truist Financial assumed coverage on shares of Cabot in a report on Monday, June 8th. They issued a “buy” rating and a $98.00 price objective on the stock.

Cabot Stock Down 0.1%

NYSE CBT opened at $88.82 on Friday. The stock has a market capitalization of $4.58 billion, a P/E ratio of 16.79, a price-to-earnings-growth ratio of 11.69 and a beta of 0.83. Cabot has a 52 week low of $58.33 and a 52 week high of $94.53. The company has a debt-to-equity ratio of 0.51, a quick ratio of 0.96 and a current ratio of 1.45. The stock has a fifty day moving average of $86.48 and a 200-day moving average of $78.33.

Cabot (NYSE:CBT) last issued its quarterly earnings results on Tuesday, May 5th. The specialty chemicals company reported $1.61 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.47 by $0.14. The business had revenue of $904.00 million for the quarter, compared to analyst estimates of $900.30 million. Cabot had a return on equity of 21.33% and a net margin of 7.97%.The firm’s revenue for the quarter was down 3.4% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $1.90 earnings per share. Cabot has set its FY 2026 guidance at 6.000-6.50 EPS. On average, equities research analysts forecast that Cabot will post 6.34 EPS for the current year.

Cabot Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, September 11th. Shareholders of record on Friday, August 28th will be given a dividend of $0.4725 per share. The ex-dividend date is Friday, August 28th. This represents a $1.89 annualized dividend and a dividend yield of 2.1%. Cabot’s payout ratio is presently 35.73%.

Institutional Inflows and Outflows

A number of large investors have recently made changes to their positions in the stock. UBS Group AG lifted its stake in Cabot by 3.5% in the fourth quarter. UBS Group AG now owns 614,178 shares of the specialty chemicals company’s stock valued at $40,708,000 after buying an additional 20,668 shares during the period. Denali Advisors LLC bought a new position in Cabot during the fourth quarter worth about $5,531,000. Jefferies Financial Group Inc. grew its position in shares of Cabot by 255.9% during the 4th quarter. Jefferies Financial Group Inc. now owns 36,570 shares of the specialty chemicals company’s stock worth $2,424,000 after buying an additional 26,294 shares during the period. Peregrine Capital Management LLC grew its position in shares of Cabot by 24.7% during the 4th quarter. Peregrine Capital Management LLC now owns 79,148 shares of the specialty chemicals company’s stock worth $5,246,000 after buying an additional 15,669 shares during the period. Finally, Norges Bank bought a new stake in shares of Cabot in the 4th quarter valued at about $49,662,000. Institutional investors and hedge funds own 93.18% of the company’s stock.

About Cabot

Cabot Corporation is a global specialty chemicals and performance materials company headquartered in Boston, Massachusetts. Founded in 1882 by Godfrey Lowell Cabot, the company has grown into a diversified manufacturer with operations across North America, Europe, Asia and Latin America. Cabot serves a wide range of end markets, including automotive, industrial, energy, and consumer products, supplying essential ingredients that enhance performance, durability and functionality.

The company operates two primary segments: Reinforcement Materials and Performance Materials.